Separating Evidence from Marketing
The global anti-ageing market is projected to exceed USD 120 billion by 2030, and Dubai sits at the centre of this growth. With new treatments launching every month, it can be difficult to distinguish genuine innovation from marketing hype. The key is to focus on treatments backed by peer-reviewed research and delivered by qualified practitioners.
At Al Das, our aesthetic and longevity teams take an evidence-first approach, every protocol we recommend has a clear mechanism of action and measurable outcomes.
Treatments with Strong Clinical Evidence
Retinoids (Vitamin A derivatives) remain the most extensively studied topical anti-ageing ingredient. Prescription-strength retinoids increase cell turnover, stimulate collagen production, and reduce fine lines, hyperpigmentation, and rough texture. Results typically become visible after 8 to 12 weeks of consistent use.
Hyaluronic acid fillers restore volume loss in the mid-face, jawline, and lips. Modern cross-linked formulations last 12 to 18 months and produce natural-looking results when administered by experienced practitioners.
Botulinum toxin (Botox) remains the gold standard for dynamic wrinkles, forehead lines, crow's feet, and frown lines. Effects last three to four months and are among the most predictable in aesthetic medicine.
